Chemical composition and antiprolifrative activity of Artemisia persica Boiss. and Artemisia turcomanica Gand. essential oils
dc.contributor.author | Nikbakht, MR | |
dc.contributor.author | Sharifi, S | |
dc.contributor.author | Emami, SA | |
dc.contributor.author | Khodaie, L | |
dc.date.accessioned | 2018-08-26T08:38:37Z | |
dc.date.available | 2018-08-26T08:38:37Z | |
dc.date.issued | 2014 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52946 | |
dc.description.abstract | Essential oils obtained from aerial parts of Artemisia persica and Artemisia turcomanica were analyzed by GC/MS. While 28 components representing 91.01 % of A. persica were identified, the identity of 50 components, constituting 81.93 % of the total oil, was confirmed in A. turcomanica. ?-thujone was the main compound (75.23%) in A. persica while the major identified phytochemicals in A. turcomanica were 1,8-cineol (19.23%), camphor (15.55%) and filifolone (15.53%). Both of the essential oils were predominantly made up of monoterpenes. Time-and dose-dependent cytotoxic effects of A. persica and A. turcomanica on MCF-7 cell line evaluated by MTT assay at 24, 48 and 72 h, showed that the highest cytotoxic effect of A. persica and A. turcomanica were appeared at 72 h incubation. At that incubation period, CI50 of A. persica was found to be 0.15 ?g/ml, while that of A. turcomanica was 0.1 ?g/ml. Thus, cytotoxicity of A. turcomanica was slightly higher than A. persica which could be attributed to the higher content of sesquiterpene present in A. turcomanica. As a conclusion, these volatile oils could have chemotherapeutic potentials. | |
dc.language.iso | English | |
dc.relation.ispartof | Research in Pharmaceutical Sciences | |
dc.subject | 1,9 cineol | |
dc.subject | 3 caren 2 ol | |
dc.subject | absinthol | |
dc.subject | alpha thujenal | |
dc.subject | antineoplastic agent | |
dc.subject | Artemisia persica essential oil | |
dc.subject | Artemisia turcomanica essential oil | |
dc.subject | beta cymene | |
dc.subject | beta elemene | |
dc.subject | borneol | |
dc.subject | bornyl acetate | |
dc.subject | camphor | |
dc.subject | cineole | |
dc.subject | cumene | |
dc.subject | delta 4 carene | |
dc.subject | essential oil | |
dc.subject | hexahydrofarnesylacetone | |
dc.subject | isothymol | |
dc.subject | jasmone | |
dc.subject | myrtenol | |
dc.subject | myrternal | |
dc.subject | pinene | |
dc.subject | sabinene | |
dc.subject | sesquiterpene | |
dc.subject | solanone | |
dc.subject | spathulenol | |
dc.subject | terpene | |
dc.subject | terpinen 4 ol | |
dc.subject | terpinene | |
dc.subject | terpinolene | |
dc.subject | unclassified drug | |
dc.subject | antiproliferative activity | |
dc.subject | Artemisia persica | |
dc.subject | Artemisia turcomanica | |
dc.subject | article | |
dc.subject | Asteraceae | |
dc.subject | breast cancer | |
dc.subject | cell viability | |
dc.subject | chemical composition | |
dc.subject | controlled study | |
dc.subject | cytotoxicity | |
dc.subject | human | |
dc.subject | in vitro study | |
dc.subject | mass fragmentography | |
dc.subject | medicinal plant | |
dc.title | Chemical composition and antiprolifrative activity of Artemisia persica Boiss. and Artemisia turcomanica Gand. essential oils | |
dc.type | Article | |
dc.citation.volume | 9 | |
dc.citation.issue | 2 | |
dc.citation.spage | 155 | |
dc.citation.epage | 163 | |
dc.citation.index | Scopus |